Abstract: Syringoma is a benign tumor of eccrine origin which arises from eccrine ducts. Syringomas are most commonly found on the eyelids in middle-aged women. Traditional treatments include surgical excision, curettage, peelings, dermabrasion and laser. We report on the successful use of fractional laser on periocular syringomas. A 53-year-old female patient with multiple periorbital syringomas underwent three sessions of fractional carbon dioxide (CO 2 ) laser. Settings of 20 watts of power, 600 μm of spacing, 800 μs of dwell, time stack 2 (Smartxide DOT, DEKA, Florence, Italy) were used. The sessions were performed monthly. Significant improvement of the esthetic appearance was observed after three sessions. There was a decrease of visible syringomas associated with an evident improvement of the skin texture, skin quality and flaccidity. No side effects were observed. We suggested continuing the treatment but the patient was satisfied with the current aspect and result. In conclusion, fractional CO 2 laser represents an effective treatment option for the treatment of periorbital syringomas.
Introduction
Syringoma is a benign adnexal tumor with eccrine differentiation that affects 0.6% of the general population with an age-peak in the second and third decade of life. Different clinical subtypes have been described, e.g. localized or generalized, sporadic, familiar and associated with Down's syndrome. Eruptive syringoma is a rare generalized subtype that has occasionally been reported as a possible paraneoplastic disease. The most common type, however, is the sporadic localized one. The majority of these tumors arise in the head and neck region, and genital manifestation is rare [1] [2] [3] [4] . In contrast to periocular syringomas, which are mostly asymptomatic, genital tumors may be associated with pruritus and pain [5] . Histologically, syringomas are symmetrical, well-circmscribed cysts and cords or strands localized in the upper dermis, without any connection to the epidermis. The proliferations have been coined comma-or tadpole-shaped, lined by single or double layers of cuboidal epithelial cells. Immunohistological investigations suggest an eccrine duct origin [6] . The solid strands seem to originate from the outer cells of the lower epidermal duct or the transitional portion between the intraepidermal duct and dermal duct in the normal eccrine gland [7] .
Case report
A 53-year-old female patient presented with multiple 1 to 3 mm large, skin-colored or slightly yellowish, periocular syringomas ( Figure 1A) . The patient provided written consent to publish the figures in this manuscript. For at least 10 years she experienced these lesions, which slowly progressed. Before treatment, the diagnosis had been confirmed elsewhere with an ablative CO 2 laser. However, the outcome after 13 sessions was poor. Therefore, this patient was referred to another type of therapy. Two years ago, she had an upper and lower blepharoplasty. There was an improvement in the skin and fat bags, but no change in the skin quality or in the syringomas. Ten years ago, she had a cardiac valve surgery. Therefore, she took 100 mg of acetylsalicylic acid per day. There was no family history of syringomas.
The patient was treated with three sessions of fractional CO 2 laser using the following parameters: 20 watts of power, 600 μm of spacing, 800 μs of dwell, time stack 2 (Smartxide DOT, DEKA, Florence, Italy). The sessions were performed monthly. Topical prilocaine-lidocaine ointment was used for anesthesia. In the beginning of the session, single shots were placed on the tiny tumors followed by complete treatment of the periorbital area using the scanner. Significant improvement of the esthetic appearance was observed after three sessions. There was a decrease of visible syringomas associated with an evident improvement of the skin texture, skin quality and flaccidity ( Figure 1B) . No side effects were observed. We suggested that she continue with the treatment, but the patient was satisfied with the outcome.
There was no relapse during the next 12 months after the last laser session.
Discussion
Periocular syringomas are often asymptomatic but may compromise the facial esthetic appearance. Therefore, patients ask for safe and effective treatment. Ablative non-fractional lasers have been used in the past with Table 1 ). Wollina previously treated 24 patients with eyelid syringomas with an erbium-doped yttrium-aluminium-garnet (Er:YAG) laser. Between one and three sessions were necessary to remove more than 80% of these tiny eccrine tumors. However, relapse occurring during the hot summer has occasionally been noted. There was no comparable rejuvenating effect as seen in the present case [8] . Fractional CO 2 laser combines fractional photothermolysis and the formation of coagulation zones with an ablative 10,600-nm wavelength, which allows for the effective treatment of photoaging, rhytides, and scars. Compared to classical CO 2 laser, recovery periods are significantly shorter and the risk of scar formation by the treatment is minimized [9] . The depth of tissue ablation is dependent on the power, fluence, spot size and density used. The dermal remodeling involves the expression of heat-shock proteins [10, 11] . Several aspects of aging skin can be improved such as dyschromia, skin texture, and fine lines [12] . For the present patient, who had been treated with ablative CO 2 laser with only slight changes, we decided to switch to the advanced technology of fractional CO 2 laser. The treatment was very successful, not only in diminishing the syringoma count, but in the rejuvenation of the whole periocular area. Further studies are needed for verification.
Conclusion
Syringomas are eccrine benign tumors of skin occurring A B [16] * BoTN -Botulinum toxin most frequently in the head and neck area. As suggested by our own experience, fractional CO 2 laser may be an effective and safe tool to improve facial appearance for the treatment of multiple periocular syringomas that poorly respond to ablative CO 2 laser. We recommend a combination of pinhole shots for syringomas, with scanner-assisted laser treatment of the whole affected area to optimize outcome.
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